What is the current market valuation of the Heart Failure POC and LOC Devices Market?

The market valuation reached 67.8 USD Million in 2024. Read More

What is the projected market size for the Heart Failure POC and LOC Devices Market by 2035?

The market is expected to grow to 363.85 USD Million by 2035. Read More

What is the expected CAGR for the Heart Failure POC and LOC Devices Market during the forecast period?

The market is projected to experience a CAGR of 16.5% from 2025 to 2035. Read More

Which companies are considered key players in the Heart Failure POC and LOC Devices Market?

Key players include Abbott, Medtronic, Boston Scientific, Philips, Bayer, Roche, Johnson & Johnson, Siemens Healthineers, and Cardinal Health. Read More

What are the primary applications of Heart Failure POC and LOC Devices?

The main applications include Monitoring, Diagnosis, Management, and Therapeutics, with valuations ranging from 12.0 to 123.85 USD Million. Read More

What types of devices are included in the Heart Failure POC and LOC Devices Market?

Device types encompass Point of Care Devices, Laboratory Onsite Devices, Wearable Devices, and Implantable Devices, with values from 12.0 to 128.85 USD Million. Read More

Who are the primary end users of Heart Failure POC and LOC Devices?

End users consist of Hospitals, Home Care Settings, Ambulatory Surgical Centers, and Specialty Clinics, with market values between 7.8 and 130.0 USD Million. Read More

What technologies are utilized in Heart Failure POC and LOC Devices?

Technologies include Electrocardiography, Ultrasound, Biomarkers, and Telemonitoring, with valuations from 12.0 to 128.85 USD Million. Read More

What patient types are targeted by Heart Failure POC and LOC Devices?

The market addresses Chronic Heart Failure Patients, Acute Heart Failure Patients, Elderly Patients, and Pediatric Patients, with values ranging from 7.02 to 145.0 USD Million. Read More

How does the market for Heart Failure POC and LOC Devices appear to be evolving?

The market appears to be expanding rapidly, driven by technological advancements and increasing patient needs, particularly in the 2025 to 2035 period. Read More

Heart Failure POC and LOC Devices Market

ID: MRFR/HC/9169-HCR

120 Pages

Vikita Thakur

Last Updated: May 15, 2026

Heart Failure POC & LOC Devices Market Research Report Information By Test Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), By Technology (Microfluidics, Array-based Systems), By End User (Hospitals & Clinics, Homecare, Specialty Centers, Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Heart Failure POC and LOC Devices Market Infographic

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Monitoring
  2. 4.1.2 Diagnosis
  3. 4.1.3 Management
  4. 4.1.4 Therapeutics
2. 4.2 Healthcare, BY Device Type (USD Million)
  1. 4.2.1 Point of Care Devices
  2. 4.2.2 Laboratory Onsite Devices
  3. 4.2.3 Wearable Devices
  4. 4.2.4 Implantable Devices
3. 4.3 Healthcare, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Home Care Settings
  3. 4.3.3 Ambulatory Surgical Centers
  4. 4.3.4 Specialty Clinics
4. 4.4 Healthcare, BY Technology (USD Million)
  1. 4.4.1 Electrocardiography
  2. 4.4.2 Ultrasound
  3. 4.4.3 Biomarkers
  4. 4.4.4 Telemonitoring
5. 4.5 Healthcare, BY Patient Type (USD Million)
  1. 4.5.1 Chronic Heart Failure Patients
  2. 4.5.2 Acute Heart Failure Patients
  3. 4.5.3 Elderly Patients
  4. 4.5.4 Pediatric Patients
6. 4.6 Healthcare, BY Region (USD Million)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Medtronic (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Philips (NL)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bayer (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Roche (CH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Johnson & Johnson (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Siemens Healthineers (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Cardinal Health (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY DEVICE TYPE
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 US MARKET ANALYSIS BY TECHNOLOGY
7. 6.7 US MARKET ANALYSIS BY PATIENT TYPE
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY DEVICE TYPE
10. 6.10 CANADA MARKET ANALYSIS BY END USER
11. 6.11 CANADA MARKET ANALYSIS BY TECHNOLOGY
12. 6.12 CANADA MARKET ANALYSIS BY PATIENT TYPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
15. 6.15 GERMANY MARKET ANALYSIS BY DEVICE TYPE
16. 6.16 GERMANY MARKET ANALYSIS BY END USER
17. 6.17 GERMANY MARKET ANALYSIS BY TECHNOLOGY
18. 6.18 GERMANY MARKET ANALYSIS BY PATIENT TYPE
19. 6.19 UK MARKET ANALYSIS BY APPLICATION
20. 6.20 UK MARKET ANALYSIS BY DEVICE TYPE
21. 6.21 UK MARKET ANALYSIS BY END USER
22. 6.22 UK MARKET ANALYSIS BY TECHNOLOGY
23. 6.23 UK MARKET ANALYSIS BY PATIENT TYPE
24. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
25. 6.25 FRANCE MARKET ANALYSIS BY DEVICE TYPE
26. 6.26 FRANCE MARKET ANALYSIS BY END USER
27. 6.27 FRANCE MARKET ANALYSIS BY TECHNOLOGY
28. 6.28 FRANCE MARKET ANALYSIS BY PATIENT TYPE
29. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
30. 6.30 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
31. 6.31 RUSSIA MARKET ANALYSIS BY END USER
32. 6.32 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
33. 6.33 RUSSIA MARKET ANALYSIS BY PATIENT TYPE
34. 6.34 ITALY MARKET ANALYSIS BY APPLICATION
35. 6.35 ITALY MARKET ANALYSIS BY DEVICE TYPE
36. 6.36 ITALY MARKET ANALYSIS BY END USER
37. 6.37 ITALY MARKET ANALYSIS BY TECHNOLOGY
38. 6.38 ITALY MARKET ANALYSIS BY PATIENT TYPE
39. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
40. 6.40 SPAIN MARKET ANALYSIS BY DEVICE TYPE
41. 6.41 SPAIN MARKET ANALYSIS BY END USER
42. 6.42 SPAIN MARKET ANALYSIS BY TECHNOLOGY
43. 6.43 SPAIN MARKET ANALYSIS BY PATIENT TYPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY END USER
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY PATIENT TYPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY APPLICATION
51. 6.51 CHINA MARKET ANALYSIS BY DEVICE TYPE
52. 6.52 CHINA MARKET ANALYSIS BY END USER
53. 6.53 CHINA MARKET ANALYSIS BY TECHNOLOGY
54. 6.54 CHINA MARKET ANALYSIS BY PATIENT TYPE
55. 6.55 INDIA MARKET ANALYSIS BY APPLICATION
56. 6.56 INDIA MARKET ANALYSIS BY DEVICE TYPE
57. 6.57 INDIA MARKET ANALYSIS BY END USER
58. 6.58 INDIA MARKET ANALYSIS BY TECHNOLOGY
59. 6.59 INDIA MARKET ANALYSIS BY PATIENT TYPE
60. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
61. 6.61 JAPAN MARKET ANALYSIS BY DEVICE TYPE
62. 6.62 JAPAN MARKET ANALYSIS BY END USER
63. 6.63 JAPAN MARKET ANALYSIS BY TECHNOLOGY
64. 6.64 JAPAN MARKET ANALYSIS BY PATIENT TYPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY END USER
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY PATIENT TYPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
71. 6.71 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
72. 6.72 MALAYSIA MARKET ANALYSIS BY END USER
73. 6.73 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
74. 6.74 MALAYSIA MARKET ANALYSIS BY PATIENT TYPE
75. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
76. 6.76 THAILAND MARKET ANALYSIS BY DEVICE TYPE
77. 6.77 THAILAND MARKET ANALYSIS BY END USER
78. 6.78 THAILAND MARKET ANALYSIS BY TECHNOLOGY
79. 6.79 THAILAND MARKET ANALYSIS BY PATIENT TYPE
80. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
81. 6.81 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
82. 6.82 INDONESIA MARKET ANALYSIS BY END USER
83. 6.83 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
84. 6.84 INDONESIA MARKET ANALYSIS BY PATIENT TYPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
86. 6.86 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
87. 6.87 REST OF APAC MARKET ANALYSIS BY END USER
88. 6.88 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
89. 6.89 REST OF APAC MARKET ANALYSIS BY PATIENT TYPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
92. 6.92 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
93. 6.93 BRAZIL MARKET ANALYSIS BY END USER
94. 6.94 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
95. 6.95 BRAZIL MARKET ANALYSIS BY PATIENT TYPE
96. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
97. 6.97 MEXICO MARKET ANALYSIS BY DEVICE TYPE
98. 6.98 MEXICO MARKET ANALYSIS BY END USER
99. 6.99 MEXICO MARKET ANALYSIS BY TECHNOLOGY
100. 6.100 MEXICO MARKET ANALYSIS BY PATIENT TYPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
102. 6.102 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
103. 6.103 ARGENTINA MARKET ANALYSIS BY END USER
104. 6.104 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
105. 6.105 ARGENTINA MARKET ANALYSIS BY PATIENT TYPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT TYPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY END USER
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY PATIENT TYPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY END USER
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY PATIENT TYPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
123. 6.123 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
124. 6.124 REST OF MEA MARKET ANALYSIS BY END USER
125. 6.125 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
126. 6.126 REST OF MEA MARKET ANALYSIS BY PATIENT TYPE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
135. 6.135 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
137. 6.137 HEALTHCARE, BY END USER, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
139. 6.139 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
141. 6.141 HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Million)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.2.5 BY PATIENT TYPE, 2025-2035 (USD Million)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.3.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.3.3 BY END USER, 2025-2035 (USD Million)
  4. 7.3.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.3.5 BY PATIENT TYPE, 2025-2035 (USD Million)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.4.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.4.3 BY END USER, 2025-2035 (USD Million)
  4. 7.4.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.4.5 BY PATIENT TYPE, 2025-2035 (USD Million)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.5.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.5.3 BY END USER, 2025-2035 (USD Million)
  4. 7.5.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.5.5 BY PATIENT TYPE, 2025-2035 (USD Million)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.6.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.6.3 BY END USER, 2025-2035 (USD Million)
  4. 7.6.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.6.5 BY PATIENT TYPE, 2025-2035 (USD Million)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.7.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.7.3 BY END USER, 2025-2035 (USD Million)
  4. 7.7.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.7.5 BY PATIENT TYPE, 2025-2035 (USD Million)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.8.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.8.3 BY END USER, 2025-2035 (USD Million)
  4. 7.8.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.8.5 BY PATIENT TYPE, 2025-2035 (USD Million)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.9.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.9.3 BY END USER, 2025-2035 (USD Million)
  4. 7.9.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.9.5 BY PATIENT TYPE, 2025-2035 (USD Million)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.10.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.10.3 BY END USER, 2025-2035 (USD Million)
  4. 7.10.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.10.5 BY PATIENT TYPE, 2025-2035 (USD Million)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.11.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.11.3 BY END USER, 2025-2035 (USD Million)
  4. 7.11.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.11.5 BY PATIENT TYPE, 2025-2035 (USD Million)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.12.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.12.3 BY END USER, 2025-2035 (USD Million)
  4. 7.12.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.12.5 BY PATIENT TYPE, 2025-2035 (USD Million)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.13.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.13.3 BY END USER, 2025-2035 (USD Million)
  4. 7.13.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.13.5 BY PATIENT TYPE, 2025-2035 (USD Million)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.14.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.14.3 BY END USER, 2025-2035 (USD Million)
  4. 7.14.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.14.5 BY PATIENT TYPE, 2025-2035 (USD Million)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.15.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.15.3 BY END USER, 2025-2035 (USD Million)
  4. 7.15.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.15.5 BY PATIENT TYPE, 2025-2035 (USD Million)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.16.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.16.3 BY END USER, 2025-2035 (USD Million)
  4. 7.16.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.16.5 BY PATIENT TYPE, 2025-2035 (USD Million)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.17.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.17.3 BY END USER, 2025-2035 (USD Million)
  4. 7.17.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.17.5 BY PATIENT TYPE, 2025-2035 (USD Million)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.18.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.18.3 BY END USER, 2025-2035 (USD Million)
  4. 7.18.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.18.5 BY PATIENT TYPE, 2025-2035 (USD Million)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.19.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.19.3 BY END USER, 2025-2035 (USD Million)
  4. 7.19.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.19.5 BY PATIENT TYPE, 2025-2035 (USD Million)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.20.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.20.3 BY END USER, 2025-2035 (USD Million)
  4. 7.20.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.20.5 BY PATIENT TYPE, 2025-2035 (USD Million)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.21.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.21.3 BY END USER, 2025-2035 (USD Million)
  4. 7.21.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.21.5 BY PATIENT TYPE, 2025-2035 (USD Million)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.22.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.22.3 BY END USER, 2025-2035 (USD Million)
  4. 7.22.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.22.5 BY PATIENT TYPE, 2025-2035 (USD Million)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.23.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.23.3 BY END USER, 2025-2035 (USD Million)
  4. 7.23.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.23.5 BY PATIENT TYPE, 2025-2035 (USD Million)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.24.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.24.3 BY END USER, 2025-2035 (USD Million)
  4. 7.24.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.24.5 BY PATIENT TYPE, 2025-2035 (USD Million)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.25.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.25.3 BY END USER, 2025-2035 (USD Million)
  4. 7.25.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.25.5 BY PATIENT TYPE, 2025-2035 (USD Million)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.26.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.26.3 BY END USER, 2025-2035 (USD Million)
  4. 7.26.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.26.5 BY PATIENT TYPE, 2025-2035 (USD Million)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.27.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.27.3 BY END USER, 2025-2035 (USD Million)
  4. 7.27.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.27.5 BY PATIENT TYPE, 2025-2035 (USD Million)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.28.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.28.3 BY END USER, 2025-2035 (USD Million)
  4. 7.28.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.28.5 BY PATIENT TYPE, 2025-2035 (USD Million)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.29.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.29.3 BY END USER, 2025-2035 (USD Million)
  4. 7.29.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.29.5 BY PATIENT TYPE, 2025-2035 (USD Million)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.30.2 BY DEVICE TYPE, 2025-2035 (USD Million)
  3. 7.30.3 BY END USER, 2025-2035 (USD Million)
  4. 7.30.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  5. 7.30.5 BY PATIENT TYPE, 2025-2035 (USD Million)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

Monitoring
Diagnosis
Management
Therapeutics

Healthcare By Device Type (USD Million, 2025-2035)

Point of Care Devices
Laboratory Onsite Devices
Wearable Devices
Implantable Devices

Healthcare By End User (USD Million, 2025-2035)

Hospitals
Home Care Settings
Ambulatory Surgical Centers
Specialty Clinics

Healthcare By Technology (USD Million, 2025-2035)

Electrocardiography
Ultrasound
Biomarkers
Telemonitoring

Healthcare By Patient Type (USD Million, 2025-2035)

Chronic Heart Failure Patients
Acute Heart Failure Patients
Elderly Patients
Pediatric Patients

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓